GOVERNMENT VIEWPOINT OF CLINICAL-TRIALS OF CARDIOVASCULAR DRUGS

被引:17
作者
TEMPLE, R
机构
关键词
D O I
10.1016/S0025-7125(16)30685-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:495 / 509
页数:15
相关论文
共 6 条
[1]   CLINICAL TRIAL DESIGN AVOIDING UNDUE PLACEBO TREATMENT [J].
AMERY, W ;
DONY, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (10) :674-679
[2]   PLACEBOS AND CONTROLLED TRIALS UNDER ATTACK [J].
LASAGNA, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (06) :373-374
[3]  
MATERSON BJ, 1978, CLIN PHARMACOL THER, V24, P192
[4]   BLOOD-CONCENTRATION AND URINARY-EXCRETION OF CAPTOPRIL (SQ14,225) IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ONOYAMA, K ;
HIRAKATA, H ;
ISEKI, K ;
FUJIMI, S ;
OMAE, T ;
KOBAYASHI, M ;
KAWAHARA, Y .
HYPERTENSION, 1981, 3 (04) :456-459
[5]  
TEMPLE R, 1983, BIOPHARMACEUTICAL SE
[6]  
TWEEDDALE MG, 1977, CLIN PHARMACOL THER, V22, P519